Clinical Trial Update: Phase I/II Study of JR-441 in Patients With Mucopolysaccharidosis Type IIIA [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 study of JR-441 in patients with Mucopolysaccharidosis Type IIIA is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mucopolysaccharidosis Type Iiia

Drugs mentioned

• JR-441

Snippet

Sponsor: JCR Pharmaceuticals Co., Ltd. | Conditions: Mucopolysaccharidosis III-A | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING